专题：Renal cell carcinoma treatment

This cluster of papers represents a comprehensive exploration of advancements in the research and treatment of renal cell carcinoma, including studies on various treatment modalities, prognostic factors, molecular characterization, nephron-sparing surgery, immunotherapy, genetic mutations, and clinical guidelines.
最新文献
Racial and Ethnic Disparities in the Utilization of Partial Nephrectomy and Robotic Surgery for Renal Cell Carcinoma

article Full Text OpenAlex

Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy

article Full Text OpenAlex

Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma

article Full Text OpenAlex

Retraction Note: Kidney cancer diagnosis and surgery selection by double Decker convolutional neural network from CT scans combined with great wall construction algorithm

article Full Text OpenAlex

Propensity Score–matched Analysis of 30-day Outcomes of Suction Versus Nonsuction Mini Percutaneous Nephrolithotomy from a Real-World Multicenter Prospective Study: Collaboration Between the European Association of Urology Endourology Section and the Asian Urological Society of Endoluminal Surgery and Technology

article Full Text OpenAlex

Stage and Histopathology, Stratification for Recurrence, Time to Recurrence, and Oncological Outcomes for T1 Renal Cell Carcinoma After Partial Nephrectomy: A 20-Year Retrospective Experience from a Single Institution

article Full Text OpenAlex

Renal cell tumours with papillary architecture: evolving concepts, classification and new emerging entities

review Full Text OpenAlex

Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists

review Full Text OpenAlex

CD70-Targeted [ 18 F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study

article Full Text OpenAlex

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup

article Full Text OpenAlex

近5年高被引文献
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

article Full Text OpenAlex 1431 FWCI206.8574

Liquid biopsy: current technology and clinical applications

review Full Text OpenAlex 797 FWCI70.6369

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

review Full Text OpenAlex 762 FWCI107.3044

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

review Full Text OpenAlex 744 FWCI67.5987

Epidemiology of Renal Cell Carcinoma: 2022 Update

review Full Text OpenAlex 695 FWCI98.641

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 633 FWCI94.6893

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

article Full Text OpenAlex 600 FWCI124.6599

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

article Full Text OpenAlex 434 FWCI43.0068

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 428 FWCI99.8248

Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

article Full Text OpenAlex 407 FWCI53.5976